文献速递其他结缔组织病

血浆外泌体RNA可作为皮肌炎的临床生物标志物和治疗靶点

Plasma exosomal RNAs have potential as both clinical biomarkers and therapeutic targets of dermatomyositis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该研究通过Illumina HiSeq 3000平台测序分析皮肌炎患者血浆外泌体中的mRNA、miRNA和lncRNA表达谱,鉴定出689个差异表达mRNA、53个差异表达miRNA和452个差异表达lncRNA。生物信息学分析提示血浆外泌体主要来源于CD8+ T细胞、调节性T细胞和自然杀伤细胞,差异表达miRNA参与自噬、TGF-β和Wnt信号通路。三个差异表达miRNA与血清学指标、器官受累和肌炎特异性自身抗体相关,血浆外泌体可通过调控三个miRNA和三个lncRNA形成的自噬网络诱导人骨骼肌成肌细胞自噬。

要点

  • 皮肌炎血浆外泌体存在689个差异表达mRNA、53个差异表达miRNA和452个差异表达lncRNA。
  • hsa-miR-125a-3p、hsa-miR-1246和hsa-miR-3614-5p与血清学指标、器官受累和肌炎特异性自身抗体相关。
  • 皮肌炎血浆外泌体通过三个miRNA和三个lncRNA形成的自噬网络诱导骨骼肌成肌细胞自噬。

核心结论

  • 皮肌炎血浆外泌体具有独特的RNA表达谱,部分miRNA可作为潜在生物标志物和治疗靶点。

研究设计与样本

  • 采用Illumina HiSeq 3000平台对皮肌炎血浆外泌体进行mRNA、miRNA和lncRNA测序分析。
  • 使用人骨骼肌成肌细胞(HSkMCs)经血浆外泌体、雷帕霉素或IFN-β刺激,以实时PCR和蛋白质印迹检测相关基因和蛋白。

主要发现

  • 在皮肌炎血浆外泌体中鉴定出689个差异表达mRNA、53个差异表达miRNA和452个差异表达lncRNA。
  • 生物信息学推断血浆外泌体主要来源于CD8+ T细胞、调节性T细胞和自然杀伤细胞,差异表达miRNA参与自噬、TGF-β和Wnt信号通路。
  • hsa-miR-125a-3p、hsa-miR-1246和hsa-miR-3614-5p与血清学指标、器官受累和肌炎特异性自身抗体相关。
  • 差异表达lncRNA参与自噬、IFN-β产生和mTOR信号通路。
  • 皮肌炎血浆外泌体通过调控三个miRNA和三个lncRNA(ENST00000584157.1、ENST00000523380.1、ENST00000560054.1)形成的自噬网络诱导HSkMCs自噬。

临床怎么用

  • 血浆外泌体RNA谱有望作为皮肌炎的潜在生物标志物用于临床评估。
  • hsa-miR-125a-3p、hsa-miR-1246和hsa-miR-3614-5p可能成为皮肌炎治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: DM is characterized by skeletal muscle weakness and cutaneous manifestations. Plasma exosomes (EXOs) contain proteins, RNAs, DNA, and lipid cargoes and are transferred among cells. If thoroughly investigated, plasma EXO RNAs could potentially improve our understanding of DM pathogenesis. We aimed to identify potential new biomarkers and therapeutic targets for DM. METHODS: The RNA (mRNA, miRNA and lncRNA) profiles of plasma EXOs were evaluated by sequencing on the Illumina HiSeq 3000 platform. Differentially expressed (DE) RNAs and bioinformatic analyses were performed. Human skeletal muscle myoblasts cells (HSkMCs) were stimulated with plasma EXOs, rapamycin or IFN-β. Real-time PCR and western blot analysis were used to detect related genes and proteins. RESULTS: A total of 689 DE mRNAs, 53 DE miRNAs and 452 DE lncRNAs were identified in DM plasma EXOs. Bioinformatic analysis inferred that plasma EXOs were secreted mainly by CD8+ T cells, regulatory T cells and natural killer cells. The DE miRNAs participated in the autophagy, TGF-β and Wnt signalling pathways. Three DE miRNAs (hsa-miR-125a-3p, hsa-miR-1246 and hsa-miR-3614-5p) were correlated with serological indices, organ involvement and myositis-specific autoantibodies. The DE lncRNAs participated in autophagy, IFN-β production and mTOR signalling. DM plasma EXOs can induce autophagy in HSkMCs by regulating three miRNAs (hsa-miR-125a-3p, hsa-miR-1246 and hsa-miR-3614-5p) and three lncRNAs (ENST00000584157.1, ENST00000523380.1 and ENST00000560054.1), which formed an autophagy network, playing a role in muscle damage. CONCLUSION: Our study provides an overview of distinct RNA profiles in DM plasma EXOs, and verified some miRNAs as potential biomarkers and therapeutic targets. The findings provide important clues for more in-depth explorations of plasma EXOs in DM.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Li L, Zuo X, Liu D, et al. Plasma exosomal RNAs have potential as both clinical biomarkers and therapeutic targets of dermatomyositis. Rheumatology (Oxford). 2022. PMID: 34698812. doi:10.1093/rheumatology/keab753

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。